Antibody to Vedolizumab ELISA

Enzyme immunoassay for the semi-quantitative determination of free antibodies to Vedolizumab (Entyvio®) in serum and plasma.

The solid phase (MTP) is coated by the drug Vedolizumab. Due to the assay design this test only measures the free antibodies which are not bound to Vedolizumab. Results are expressed in AU (arbitrary units).

Reference: IG-BB116

Barcode: 8699316552635

Legal Status: CE-Mark

Intended Use: This kit has been developed for the detection of anti-drug antibodies in research and diagnostic uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.

Assay Design:

IG-BB116

Related Documents

 
 

Quality Control Certificates

  

Entyvio® is a trademark of Takeda Pharmaceuticals Inc.

The Kit at a glance:

IG-BB116

Required Volume (µL) 10
Incubation Time (min) 135
Sample Serum or Plasma
Package Size 96 Tests
Results in Arbitrary Units (AU/mL)
Cut-Off (AU/mL) 3
Shelf Life (years) 2